Terms: = Breast cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun
1484 results:
1. Abrogating PDK4 activates autophagy-dependent ferroptosis in breast cancer via ASK1/JNK pathway.
Shi W; Wang J; Chen J; Jin X; Wang Y; Yang L
J Cancer Res Clin Oncol; 2024 Apr; 150(4):218. PubMed ID: 38678126
[TBL] [Abstract] [Full Text] [Related]
2. Unveiling the Mechanism of the ChaiShao Shugan Formula Against Triple-Negative breast cancer.
Fan T; Huang Y; Liu Z; Huang J; Ke B; Rong Y; Qiu H; Zhang B
Drug Des Devel Ther; 2024; 18():1115-1131. PubMed ID: 38618280
[TBL] [Abstract] [Full Text] [Related]
3. Active substance and mechanisms of Actinidia chinensis Planch for the treatment of breast cancer was explored based on network pharmacology and in silico study.
Xu Y; Yang J; Han X; Gan C; Wei X
Medicine (Baltimore); 2024 Apr; 103(15):e37829. PubMed ID: 38608062
[TBL] [Abstract] [Full Text] [Related]
4. Parabens promotes invasive properties of multiple human cells: A potential cancer-associated adverse outcome pathway.
Wang L; Chen L; Schlenk D; Li F; Liu J
Sci Total Environ; 2024 May; 926():172015. PubMed ID: 38547973
[TBL] [Abstract] [Full Text] [Related]
5. Steroid receptor coactivator 1 promotes human hepatocellular carcinoma invasiveness through enhancing MMP-9.
Tong Z; Zhang Y; Guo P; Wang W; Chen Q; Jin J; Liu S; Yu C; Mo P; Zhang L; Huang J
J Cell Mol Med; 2024 Apr; 28(7):e18171. PubMed ID: 38506084
[TBL] [Abstract] [Full Text] [Related]
6. Molecular docking, ADMET profiling of gallic acid and its derivatives (N-alkyl gallamide) as apoptosis agent of breast cancer MCF-7 Cells.
Arsianti A; Nur Azizah N; Erlina L
F1000Res; 2022; 11():1453. PubMed ID: 38463030
[TBL] [Abstract] [Full Text] [Related]
7. Multiomic profiling of breast cancer cells uncovers stress MAPK-associated sensitivity to AKT degradation.
Erickson EC; You I; Perry G; Dugourd A; Donovan KA; Crafter C; Johannes JW; Williamson S; Moss JI; Ros S; Ziegler RE; Barry ST; Fischer ES; Gray NS; Madsen RR; Toker A
Sci Signal; 2024 Feb; 17(825):eadf2670. PubMed ID: 38412255
[TBL] [Abstract] [Full Text] [Related]
8. Drug-resilient cancer Cell Phenotype Is Acquired via Polyploidization Associated with Early Stress Response Coupled to HIF2α Transcriptional Regulation.
Carroll C; Manaprasertsak A; Boffelli Castro A; van den Bos H; Spierings DCJ; Wardenaar R; Bukkuri A; Engström N; Baratchart E; Yang M; Biloglav A; Cornwallis CK; Johansson B; Hagerling C; Arsenian-Henriksson M; Paulsson K; Amend SR; Mohlin S; Foijer F; McIntyre A; Pienta KJ; Hammarlund EU
Cancer Res Commun; 2024 Mar; 4(3):691-705. PubMed ID: 38385626
[TBL] [Abstract] [Full Text] [Related]
9. Inhibition of ATM promotes PD-L1 expression by activating JNK/c-jun/TNF-α signaling axis in triple-negative breast cancer.
Liu C; Qian X; Yu C; Xia X; Li J; Li Y; Xie Y; Gao G; Song Y; Zhang M; Xue H; Wang X; Sun H; Liu J; Deng W; Guo X
Cancer Lett; 2024 Apr; 586():216642. PubMed ID: 38278470
[TBL] [Abstract] [Full Text] [Related]
10. Endosomal protein expression of γ1-adaptin is associated with tumor growth activity and relapse-free survival in breast cancer.
Hoshi N; Uemura T; Tachibana K; Abe S; Murakami-Nishimagi Y; Okano M; Noda M; Saito K; Kono K; Ohtake T; Waguri S
Breast Cancer; 2024 Mar; 31(2):305-316. PubMed ID: 38265632
[TBL] [Abstract] [Full Text] [Related]
11. Homeobox Protein PROX1 Expression is Negatively Regulated by Histone Deacetylase 1 and c-jun Complex in MDA-MB-231 Human breast cancer Cells.
Jeong M; Jung E; Oh S; Shin SY
Folia Biol (Praha); 2023; 69(3):81-90. PubMed ID: 38206773
[TBL] [Abstract] [Full Text] [Related]
12. Protein disulfide isomerase family member 4 promotes triple-negative breast cancer tumorigenesis and radiotherapy resistance through JNK pathway.
Tao J; Xue C; Cao M; Ye J; Sun Y; Chen H; Guan Y; Zhang W; Zhang W; Yao Y
Breast Cancer Res; 2024 Jan; 26(1):1. PubMed ID: 38167446
[TBL] [Abstract] [Full Text] [Related]
13. The APE1/REF-1 and the hallmarks of cancer.
Siqueira PB; de Sousa Rodrigues MM; de Amorim ÍSS; da Silva TG; da Silva Oliveira M; Rodrigues JA; de Souza da Fonseca A; Mencalha AL
Mol Biol Rep; 2024 Jan; 51(1):47. PubMed ID: 38165468
[TBL] [Abstract] [Full Text] [Related]
14. Progestins and breast cancer hallmarks: The role of the ERK1/2 and JNK pathways in estrogen receptor positive breast cancer cells.
Louw-du Toit R; Simons M; Africander D
J Steroid Biochem Mol Biol; 2024 Mar; 237():106440. PubMed ID: 38048919
[TBL] [Abstract] [Full Text] [Related]
15. PARP7-mediated ADP-ribosylation of FRA1 promotes cancer cell growth by repressing IRF1- and IRF3-dependent apoptosis.
Manetsch P; Böhi F; Nowak K; Leslie Pedrioli DM; Hottiger MO
Proc Natl Acad Sci U S A; 2023 Dec; 120(49):e2309047120. PubMed ID: 38011562
[TBL] [Abstract] [Full Text] [Related]
16. Epigenetic Dysregulation and Its Correlation with the Steroidogenic Machinery Impacting breast Pathogenesis: Data Mining and Molecular Insights into Therapeutics.
Manna PR; Yang S; Reddy PH
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003678
[TBL] [Abstract] [Full Text] [Related]
17. Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer.
Saatci O; Cetin M; Uner M; Tokat UM; Chatzistamou I; Ersan PG; Montaudon E; Akyol A; Aksoy S; Uner A; Marangoni E; Sajish M; Sahin O
Nat Commun; 2023 Nov; 14(1):6997. PubMed ID: 37914699
[TBL] [Abstract] [Full Text] [Related]
18. Architecture and topologies of gene regulatory networks associated with breast cancer, adjacent normal, and normal tissues.
Kumar S; Vindal V
Funct Integr Genomics; 2023 Oct; 23(4):324. PubMed ID: 37878223
[TBL] [Abstract] [Full Text] [Related]
19. Huaier suppresses cisplatin resistance in non-small cell lung cancer by inhibiting the JNK/jun/IL-8 signaling pathway.
Jin H; Liu C; Liu X; Wang H; Zhang Y; Liu Y; Li J; Yu Z; Liu HX
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117270. PubMed ID: 37832810
[TBL] [Abstract] [Full Text] [Related]
20. FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression.
Huang YC; Chen WC; Yu CL; Chang TK; I-Chin Wei A; Chang TM; Liu JF; Wang SW
Biochem Pharmacol; 2023 Dec; 218():115853. PubMed ID: 37832794
[TBL] [Abstract] [Full Text] [Related]
[Next]
